Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 671, Issue 1-2, 2009, Pages 76-83

  Gemignani, Federica ^a   Neri, Monica ^b   Bottari, Fabio ^a   Barale, Roberto ^a   Canessa, Pier Aldo ^c   Canzian, Federico ^d   Ceppi, Marcello ^b   Spitaleri, Irene ^e   Cipollini, Monica ^a   Ivaldi, Gian Paolo ^f   Mencoboni, Manlio ^g   Scaruffi, Paola ^b   Tonini, Gian Paolo ^b   Ugolini, Donatella ^b,i   Mutti, Luciano ^j,k   Bonassi, Stefano ^h   Landi, Stefano ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Ospedale S Bartolomeo   (Italy)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e UNIVERSITY OF FLORENCE   (Italy)

^f Pneumology   (Italy)

^g Medical Oncology   (Italy)

^h IRCCS SAN RAFFAELE PISANA   (Italy)

ⁱ UNIVERSITY OF GENOA   (Italy)

^j Laboratorio di Oncologia Clinica   (Italy)

^k UNIVERSITY OF EASTERN PIEDMONT   (Italy)

more..

Author keywords

DNA repair; Mesothelioma; Microarray analysis; Molecular epidemiology; Oxidative stress; Single nucleotide polymorphism

Indexed keywords

ACYLTRANSFERASE; ARYLAMINE ACETYLTRANSFERASE; ASBESTOS; BIOLOGICAL MARKER; EPOXIDE HYDROLASE 1; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 5; GLUTATHIONE TRANSFERASE M1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN MLH1; PROTEIN MSH3; RAD52 PROTEIN; RECQL PROTEIN; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOMIC INSTABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; NUCLEIC ACID BASE SUBSTITUTION; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENOMIC INSTABILITY; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; PLEURAL NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; XENOBIOTICS;

EID: 70350545707     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2009.09.003     Document Type: Article

References (28)

1. Toyooka S., Kishimoto T., and Date H. Advances in the molecular biology of malignant mesothelioma. Acta Med. Okayama 62 (2008) 1-7
2. Zanella C.L., Posada J., Tritton T.R., and Mossman B.T. Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor. Cancer Res. 56 (1996) 5334-5338
3. Motadi L.R., Misso N.L., Dlamini Z., and Bhoola K.D. Molecular genetics and mechanisms of apoptosis in carcinomas of the lung and pleura: therapeutic targets. Int. Immunopharmacol. 7 (2007) 1934-1947
4. Xu A., Zhou H., Yu D.Z., and Hei T.K. Mechanisms of the genotoxicity of crocidolite asbestos in mammalian cells: implication from mutation patterns induced by reactive oxygen species. Environ. Health Perspect. 110 (2002) 1003-1008
5. Kamp D.W., and Weitzman S.A. The molecular basis of asbestos induced lung injury. Thorax 54 (1999) 638-652
6. Kleinbaum D.G., Morgenstern H., and Kupper L.L. Selection bias in epidemiologic studies. Am. J. Epidemiol. 113 (1981) 452-463
7. Schurkes C., Brock W., Abel J., and Unfried K. Induction of 8-hydroxydeoxyguanosine by man made vitreous fibres and crocidolite asbestos administered intraperitoneally in rats. Mutat. Res. 553 (2004) 59-65
8. Topinka J., Loli P., Georgiadis P., Dusinska M., Hurbankova M., Kovacikova Z., Volkovova K., Kazimirova A., Barancokova M., Tatrai E., Oesterle D., Wolff T., and Kyrtopoulos S.A. Mutagenesis by asbestos in the lung of lambda-lacI transgenic rats. Mutat. Res. 553 (2004) 67-78
9. Hirvonen A., Pelin K., Tammilehto L., Karjalainen A., Mattson K., and Linnainmaa K. Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma. Cancer Res. 55 (1995) 2981-2983
10. Hirvonen A., Saarikoski S.T., Linnainmaa K., Koskinen K., Husgafvel-Pursiainen K., Mattson K., and Vainio H. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. J. Natl. Cancer Inst. 88 (1996) 1853-1856
11. Landi S., Gemignani F., Neri M., Barale R., Bonassi S., Bottari F., Canessa P.A., Canzian F., Ceppi M., Filiberti R., Ivaldi G.P., Mencoboni M., Scaruffi P., Tonini G.P., Mutti L., and Puntoni R. Polymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma. Int. J. Cancer 120 (2007) 2739-2743
12. Neri M., Filiberti R., Taioli E., Garte S., Paracchini V., Bolognesi C., Canessa P.A., Fontana V., Ivaldi G.P., Verna A., Bonassi S., and Puntoni R. Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure. Mutat. Res. 592 (2005) 36-44
13. Smith C.M., Kelsey K.T., Wiencke J.K., Leyden K., Levin S., and Christiani D.C. Inherited glutathione-S-transferase deficiency is a risk factor for pulmonary asbestosis. Cancer Epidemiol. Biomark. Prev. 3 (1994) 471-477
14. Neri M., Ugolini D., Dianzani I., Gemignani F., Landi S., Cesario A., Magnani C., Mutti L., Puntoni R., and Bonassi S. Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases. Mutat. Res. (2008)
15. Neri M., Taioli E., Filiberti R., Paolo I.G., Aldo C.P., Verna A., Marroni P., Puntoni R., Hirvonen A., and Garte S. Metabolic genotypes as modulators of asbestos-related pleural malignant mesothelioma risk: a comparison of Finnish and Italian populations. Int. J. Hyg. Environ. Health 209 (2006) 393-398
16. de Boer J.G. Polymorphisms in DNA repair and environmental interactions. Mutat. Res. 509 (2002) 201-210
17. Dianzani I., Gibello L., Biava A., Giordano M., Bertolotti M., Betti M., Ferrante D., Guarrera S., Betta G.P., Mirabelli D., Matullo G., and Magnani C. Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study. Mutat. Res. 599 (2006) 124-134
18. Gemignani F., Landi S., Vivant F., Zienolddiny S., Brennan P., and Canzian F. A catalogue of polymorphisms related to xenobiotic metabolism and cancer susceptibility. Pharmacogenetics 12 (2002) 459-463
19. Landi S., Gemignani F., Gioia-Patricola L., Chabrier A., and Canzian F. Evaluation of a microarray for genotyping polymorphisms related to xenobiotic metabolism and DNA repair. Biotechniques 35 (2003) 816-817
20. Landi S., Gemignani F., Monnier S., and Canzian F. A database of single-nucleotide polymorphisms and a genotyping microarray for genetic epidemiology of lung cancer. Exp. Lung Res. 31 (2005) 223-258
21. Gemignani F., Perra C., Landi S., Canzian F., Kurg A., Tonisson N., Galanello R., Cao A., Metspalu A., and Romeo G. Reliable detection of beta-thalassemia and G6PD mutations by a DNA microarray. Clin. Chem. 48 (2002) 2051-2054
22. Kurg A., Tonisson N., Georgiou I., Shumaker J., Tollett J., and Metspalu A. Arrayed primer extension: solid-phase four-color DNA resequencing and mutation detection technology. Genet. Test. 4 (2000) 1-7
23. Tonisson N., Zernant J., Kurg A., Pavel H., Slavin G., Roomere H., Meiel A., Hainaut P., and Metspalu A. Evaluating the arrayed primer extension resequencing assay of TP53 tumor suppressor gene. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 5503-5508
24. Guo Z., Guilfoyle R.A., Thiel A.J., Wang R., and Smith L.M. Direct fluorescence analysis of genetic polymorphisms by hybridization with oligonucleotide arrays on glass supports. Nucleic Acids Res. 22 (1994) 5456-5465
25. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology 1 (1990) 43-46
26. Gennaro V., Ugolini D., Viarengo P., Benfatto L., Bianchelli M., Lazzarotto A., Montanaro F., and Puntoni R. Incidence of pleural mesothelioma in Liguria Region, Italy (1996-2002). Eur. J. Cancer 41 (2005) 2709-2714
27. Betti M., Neri M., Ferrante D., Landi S., Biava A., Gemignani F., Bertolotti M., Mirabelli D., Padoan M., Ugolini D., Botta M., Bonassi S., Magnani C., and Dianzani I. Pooled analysis of NAT2 genotypes as risk factors for asbestos-related malignant mesothelioma. Int. J. Hyg. Environ. Health (2008)
28. Ugolini D., Neri M., Canessa P.A., Casilli C., Catrambone G., Ivaldi G.P., Lando C., Marroni P., Paganuzzi M., Parodi B., Visconti P., Puntoni R., and Bonassi S. The CREST biorepository: a tool for molecular epidemiology and translational studies on malignant mesothelioma, lung cancer, and other respiratory tract diseases. Cancer Epidemiol Biomarkers Prev. 17 11 (2008) 3013-3019